Rhino-orbital mucormycosis in a COVID-19 patient.
Rhino-orbital mucormycosis in a COVID-19 patient.
复制标题
DOI:
10.1136/bcr-2021-244232
复制
发表时间:
2021-06-24
期刊:
影响因子:
0.9
通讯作者:
Singh S
中科院分区:
文献类型:
--
作者:
Baskar HC;Chandran A;Reddy CS;Singh S
A 28-year-old male patient presented with a 5-day history of sudden vision loss and swelling of the right eye along with a history of cough and fever. He denied any previous ocular trauma or nasal symptoms. His previous medical charts ruled out any cause for immunosuppression except a history of acute viral hepatitis-A 5 years back. General examination was unremarkable. Ocular examination revealed proptosis of the right eye with conjunctival congestion, chemosis, erythematous and swollen upper and lower eyelids (figure 1A). He denied perception of light on the right eye with a fixed dilated pupil and complete ophthalmoplegia. Examination of other eye and nose was unremarkable. An oropharyngeal swab for reverse-transcriptase PCR (RT-PCR) was positive for SARS-CoV-2 virus with a cycle threshold value of 30. The routine blood investigations were unremarkable. The fasting and 2-hour postprandial blood sugar values were within normal limits with a haemoglobin A1c value of 5.5%. A contrastenhanced CT scan of nose and paranasal sinus with orbit showed right intraconal and retrobulbar soft tissue density along with mucosal thickening in the right ethmoid sinus (figure 1B). His chest radiograph showed diffuse bilateral ground-glass opacities consistent with COVID-19 pneumonia (figure 1C). An orbital biopsy revealed broad aseptate fungal hyphae suggestive of mucormycosis. Immune deficiency syndromes including HIV (ELISA test) and hypocomplementemia were ruled out owing to the presence of an opportunistic fungal infection in a healthy adult. Intravenous broad-spectrum antibiotics (meropenem 500 mg thrice a day and teicoplanin 200 mg twice a day) were administered for probable bacterial superinfection of COVID-19 pneumonia along with liposomal amphotericin-B for rhino-orbital mucormycosis. The presence of active fulminant mucormycosis precluded the use of corticosteroid therapy. The patient underwent right-side orbital exenteration and ethmoid sinus debridement under general anaesthesia with universal precautions using optimum personal protective equipment. He had completed the course of parenteral antifungal therapy and clinically disease free at 2-month follow-up period post COVID-19 recovery.Rhino-orbital mucormycosis is an acute and fulminant fungal infection caused by the angioinvasive fungi of the family Mucoraceae and seen usually among immunocompromised subjects and patients with decompensated diabetes. 1 Though the primary site of fungal inoculation is the nose and paranasal sinuses, these aggressive fungi
登录
查看更多内容
影响因子:
3.6
作者:
Werthman-Ehrenreich, Amanda
通讯作者:
Werthman-Ehrenreich, Amanda
影响因子:
3.1
作者:
Sen M;Lahane S;Lahane TP;Parekh R;Honavar SG
通讯作者:
Honavar SG
DOI:
10.7759/cureus.10726
发表时间:
2020-09-30
期刊:
Cureus
影响因子:
--
作者:
Mehta S;Pandey A
通讯作者:
Pandey A
影响因子:
5.5
作者:
Garg D;Muthu V;Sehgal IS;Ramachandran R;Kaur H;Bhalla A;Puri GD;Chakrabarti A;Agarwal R
通讯作者:
Agarwal R
影响因子:
11.8
作者:
Petrikkos, George;Skiada, Anna;Kontoyiannis, Dimitrios P.
通讯作者:
Kontoyiannis, Dimitrios P.